Cycle for Survival is the movement to beat rare cancers. 100% of every dollar raised is directly allocated to rare cancer research at Memorial Sloan Kettering Cancer Center (MSK) within six months of the close of fundraising annually. Cycle for Survival has raised over $376 million since it first began in 2007. This milestone reflects the determination and generosity of our passionate community. Approximately 50% of people with cancer are battling a rare cancer, but they often have limited or no treatment options because rare cancer research is drastically underfunded. Together with founding partner, Equinox, Cycle for Survival funding has supported pioneering clinical trials, research studies and major scientific initiatives at MSK, Read more